MedTrace Logo

Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

NCT05383521 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-06-11

No results posted yet for this study

Summary

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

Conditions

  • Trichomonas Vaginitis

Interventions

DRUG

Tinidazole 56

Tinidazole , 2g， twice daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

DRUG

Tinidazole 42

Tinidazole , 1g, three times daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

Sponsors & Collaborators

  • Shangrong Fan

    lead OTHER

Principal Investigators

  • Shangrong Fan Fan, M.D. · Peking University Shenzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05383521 on ClinicalTrials.gov